BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31848942)

  • 21. c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis.
    Steeb T; Wessely A; Petzold A; Kohl C; Erdmann M; Berking C; Heppt MV
    Eur J Cancer; 2021 Nov; 157():348-357. PubMed ID: 34562816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational Profile of Driver Genes in Brazilian Melanomas.
    Vicente ALSA; Crovador CS; Macedo G; Scapulatempo-Neto C; Reis RM; Vazquez VL
    J Glob Oncol; 2019 Nov; 5():1-14. PubMed ID: 31756131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
    Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature.
    Satzger I; Küttler U; Völker B; Schenck F; Kapp A; Gutzmer R
    Dermatology; 2010; 220(1):77-81. PubMed ID: 19996579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-scale analysis of KIT aberrations in Chinese patients with melanoma.
    Kong Y; Si L; Zhu Y; Xu X; Corless CL; Flaherty KT; Li L; Li H; Sheng X; Cui C; Chi Z; Li S; Han M; Mao L; Lu A; Guo J
    Clin Cancer Res; 2011 Apr; 17(7):1684-91. PubMed ID: 21325067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
    Yaman B; Akalin T; Kandiloğlu G
    Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular profile of metastatic melanoma in Australia.
    Lyle M; Haydu LE; Menzies AM; Thompson JF; Saw RP; Spillane AJ; Kefford RF; Mann GJ; Cooper WA; Yu B; Scolyer RA; O'Toole SA; Long GV
    Pathology; 2016 Feb; 48(2):188-93. PubMed ID: 27020391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations.
    Schoenewolf NL; Bull C; Belloni B; Holzmann D; Tonolla S; Lang R; Mihic-Probst D; Andres C; Dummer R
    Eur J Cancer; 2012 Aug; 48(12):1842-52. PubMed ID: 22464346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dark homogeneous streak dermoscopic pattern correlating with specific KIT mutations in melanoma.
    Sanchez MI; Rabinovitz HS; Oliviero MC; Elgart GW; Perez C; Puig S; Malvehy J; Grichnik JM
    JAMA Dermatol; 2014 Jun; 150(6):633-9. PubMed ID: 24695820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c kit in oral mucosal melanoma.
    Tsiambas E; Mastronikolis NS; Ragos V; Fotiades PP
    J BUON; 2018; 23(6):1927-1928. PubMed ID: 30610823
    [No Abstract]   [Full Text] [Related]  

  • 32. Melanoma hyperpigmentation is strongly associated with KIT alterations.
    Wu JM; Alvarez H; García P; Rojas PL; Wong G; Maitra A; Antonescu C; Montgomery EA
    Am J Dermatopathol; 2009 Oct; 31(7):619-25. PubMed ID: 19652585
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
    Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
    [No Abstract]   [Full Text] [Related]  

  • 34. Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases.
    Cinotti E; Chevallier J; Labeille B; Cambazard F; Thomas L; Balme B; Leccia MT; D'Incan M; Vercherin P; Douchet C; Rubegni P; Perrot JL
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1834-1840. PubMed ID: 28543798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of BRAF mutations in UV-protected mucosal melanomas.
    Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
    J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIT mutations in Russian patients with mucosal melanoma.
    Abysheva SN; Iyevleva AG; Efimova NV; Mokhina YB; Sabirova FA; Ivantsov AO; Artemieva AS; Togo AV; Moiseyenko VM; Matsko DE; Imyanitov EN
    Melanoma Res; 2011 Dec; 21(6):555-9. PubMed ID: 21971089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey.
    Mikkelsen LH; Larsen AC; von Buchwald C; Drzewiecki KT; Prause JU; Heegaard S
    APMIS; 2016 Jun; 124(6):475-86. PubMed ID: 27004972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIT and melanoma predisposition in pigs: sequence variants and association analysis.
    Fernández-Rodríguez A; Estellé J; Blin A; Muñoz M; Créchet F; Demenais F; Vincent-Naulleau S; Bourneuf E
    Anim Genet; 2014 Jun; 45(3):445-8. PubMed ID: 24628300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas.
    Satzger I; Schaefer T; Kuettler U; Broecker V; Voelker B; Ostertag H; Kapp A; Gutzmer R
    Br J Cancer; 2008 Dec; 99(12):2065-9. PubMed ID: 19018266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIT gene exon 11 mutations in canine malignant melanoma.
    Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
    Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.